Drug Shortage Report for JAMP-INDAPAMIDE

Last updated on 2018-12-19 History
Report ID 3805
Drug Identification Number 02373912
Brand name JAMP-INDAPAMIDE
Common or Proper name Indapamide
Company Name JAMP PHARMA CORPORATION
Market Status CANCELLED POST MARKET
Active Ingredient(s) INDAPAMIDE
Strength(s) 2.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C03BA
ATC description LOW-CEILING DIURETICS, EXCL THIAZIDES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2016-09-15
Estimated end date 2020-12-31
Actual end date
Shortage status Actual shortage
Updated date 2018-12-19
Company comments supply issue
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2018-12-19 French Compare
v10 2018-12-19 English Compare
v9 2018-10-15 French Compare
v8 2018-10-15 English Compare
v7 2017-09-25 French Compare
v6 2017-09-25 English Compare
v5 2017-09-25 English Compare
v4 2017-03-21 French Compare
v3 2017-03-21 English Compare
v2 2017-03-21 French Compare
v1 2017-03-21 English Compare

Showing 1 to 11 of 11